Latest Interviews
"I am excited about Janssen’s aspirational vision to eliminate cancer. With targeted therapies and immunotherapies, cancer treatment can be more effective and less toxic, enabling individuals to manage their disease while also maintaining their quality of life."
60188
"AFC’s core technology differentiators include energetic chemistry, high potency manufacturing, and extensive chromatographic separation capabilities."
60186
RF: "Our experience in developing proprietary chemical processes and alternative solutions to support the generic API industry has been instrumental in rapidly expanding our CDMO activities."
60184
"Interestingly, despite increasingly challenging operating environments, the industry’s ounce production continues to maintain or improve. That speaks to the creativeness and technical expertise of the whole value chain of the industry."
60182
"The changing regulatory environment, pressure to streamline the permitting process, and significant investment coming into the state are all driving real-time planning, creative strategies, and good organization."
60180
"We contribute by using advanced technology and data to reduce failures and downtime, providing confidence in continuous operations. The shift we see in technological development is from increasing size and scale of operations to increasing efficiency and improving processes."